|
LDLRAD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.75659999998879E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.958800E-03 |
| Normal-vs-Stage2 |
4.966200E-02 |
| Normal-vs-Stage3 |
9.07059982679925E-11 |
| Normal-vs-Stage4 |
6.24699999999256E-05 |
| Stage1-vs-Stage2 |
8.064400E-01 |
| Stage1-vs-Stage3 |
3.341800E-01 |
| Stage1-vs-Stage4 |
2.579000E-01 |
| Stage2-vs-Stage3 |
6.264800E-01 |
| Stage2-vs-Stage4 |
5.214200E-01 |
| Stage3-vs-Stage4 |
6.390400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.415690E-04 |
| Normal-vs-AfricanAmerican |
1.53271999999705E-05 |
| Normal-vs-Asian |
8.688500E-02 |
| Caucasian-vs-AfricanAmerican |
3.632400E-01 |
| Caucasian-vs-Asian |
2.944200E-01 |
| AfricanAmerican-vs-Asian |
7.040300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.177400E-04 |
| Normal-vs-Female |
5.22470955388599E-13 |
| Male-vs-Female |
1.579820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.42660000000705E-05 |
| Normal-vs-Age(41-60Yrs) |
4.88699969380946E-10 |
| Normal-vs-Age(61-80Yrs) |
1.623630E-02 |
| Normal-vs-Age(81-100Yrs) |
4.774200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.778200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.780400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.220800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.783400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.130200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.857800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.371800E-04 |
| Normal-vs-Grade 2 |
7.818700E-03 |
| Normal-vs-Grade 3 |
7.86437581723476E-12 |
| Normal-vs-Grade 4 |
3.5953000000033E-05 |
| Grade 1-vs-Grade 2 |
7.130400E-01 |
| Grade 1-vs-Grade 3 |
1.847450E-01 |
| Grade 1-vs-Grade 4 |
3.167800E-01 |
| Grade 2-vs-Grade 3 |
1.938630E-01 |
| Grade 2-vs-Grade 4 |
3.507200E-01 |
| Grade 3-vs-Grade 4 |
4.367000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
2.01020311507705E-11 |
| ccA subtype-vs-ccB subtype |
9.039800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.789680E-02 |
| Normal-vs-N1 |
4.713600E-02 |
| N0-vs-N1 |
1.588560E-01 |
|
|
